AI MARKET SCANNING

Cardiff Oncology Inc

🏛️ NASDAQ 📁 Health Technology 🏭 Medical Specialties
AVG HISTORICAL GAP -0.19%
MAX GAP RECORD -18.73%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $CRDF
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 11, 2026 Earnings Release 2026-08-11 (AFTER CLOSE)
-4.76%
May 13, 2026 Earnings Release 2026-05-13 (AFTER CLOSE)
+0.59%
Feb 24, 2026 Earnings Release 2026-02-24 (AFTER CLOSE)
+3.53%
Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE)
-2.67%
Jul 29, 2025 Earnings Release 2025-07-29 (AFTER CLOSE)
-18.73%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
+0.80%
Feb 27, 2025 Earnings Release 2025-02-27 (AFTER CLOSE)
-0.74%
Nov 07, 2024 Earnings Release 2024-11-07 (AFTER CLOSE)
+0.98%

VOLATILITY & GAP BIAS

AVG GAP MOVE 5.2%
Bullish Gaps (6)
Bearish Gaps (5)
Neutral / Flat (4)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $CRDF

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. The firm is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics. Its…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗